BioLife Solutions, Inc. Payments to Develop Software
BioLife Solutions, Inc. (BLFS) reported Payments to Develop Software of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToDevelopSoftware · last filed 2018-03-09
- BioLife Solutions, Inc. payments to develop software for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. payments to develop software for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. payments to develop software for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. payments to develop software for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. payments to develop software for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- BioLife Solutions, Inc. payments to develop software for fiscal 2016 was $1.11M, a 13.24% decline from fiscal 2015.
- BioLife Solutions, Inc. payments to develop software for fiscal 2015 was $1.28M.
- BioLife Solutions, Inc. payments to develop software for fiscal 2014 was $0.00.
| Period end | Payments to Develop Software 3 month | Payments to Develop Software 6 month | Payments to Develop Software 9 month | Payments to Develop Software 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-09 | $0.00 10-K · filed 2018-03-09 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | $256.22K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | $256.22K derived: sum of 3 quarters · filed 2018-03-09 | $418.63K derived: sum of 4 quarters · filed 2018-03-09 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-12 | $256.22K derived: sum of 2 quarters · filed 2018-03-09 | $418.63K derived: sum of 3 quarters · filed 2018-03-09 | $561.14K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-12-31 | $256.22K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $418.63K derived: sum of 2 quarters · filed 2018-03-09 | $561.14K derived: sum of 3 quarters · filed 2018-03-09 | $1.11M 10-K · filed 2018-03-09 |
| 2016-09-30 | $162.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $304.92K derived: sum of 2 quarters · filed 2017-11-09 | $857.45K 10-Q · filed 2017-11-09 | $1.25M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $142.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $695.04K 10-Q · filed 2017-08-11 | $1.08M derived: sum of 3 quarters · filed 2017-08-11 | $1.48M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | $552.53K 10-Q · filed 2017-05-12 | $941.16K derived: sum of 2 quarters · filed 2017-05-12 | $1.34M derived: sum of 3 quarters · filed 2017-05-12 | $1.84M derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $388.62K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $786.21K derived: sum of 2 quarters · filed 2017-03-15 | $1.28M derived: sum of 3 quarters · filed 2017-03-15 | $1.28M 10-K · filed 2017-03-15 |
| 2015-09-30 | $397.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $895.06K derived: sum of 2 quarters · filed 2016-11-10 | $895.06K 10-Q · filed 2016-11-10 | $895.06K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $497.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $497.48K 10-Q · filed 2016-08-11 | $497.48K derived: sum of 3 quarters · filed 2016-08-11 | $497.48K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 | $0.00 derived: sum of 2 quarters · filed 2016-05-16 | $0.00 derived: sum of 3 quarters · filed 2016-05-16 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 10-K · filed 2016-02-25 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $0.00 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |